• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.

Disruption of the precise balance of positive and negative molecular regulators of blood and lymphatic vessel growth can lead to myriad diseases. Although dozens of natural inhibitors of hemangiogenesis have been identified, an endogenous selective inhibitor of lymphatic vessel growth has not to our knowledge been previously described. We report the existence of a splice variant of the gene encoding vascular endothelial growth factor receptor-2 (Vegfr-2) that encodes a secreted form of the protein, designated soluble Vegfr-2 (sVegfr-2), that inhibits developmental and reparative lymphangiogenesis by blocking Vegf-c function. Tissue-specific loss of sVegfr-2 in mice induced, at birth, spontaneous lymphatic invasion of the normally alymphatic cornea and hyperplasia of skin lymphatics without affecting blood vasculature. Administration of sVegfr-2 inhibited lymphangiogenesis but not hemangiogenesis induced by corneal suture injury or transplantation, enhanced corneal allograft survival and suppressed lymphangioma cellular proliferation. Naturally occurring sVegfr-2 thus acts as a molecular uncoupler of blood and lymphatic vessels; modulation of sVegfr-2 might have therapeutic effects in treating lymphatic vascular malformations, transplantation rejection and, potentially, tumor lymphangiogenesis and lymphedema (pages 993-994).

Pubmed ID: 19668192

Authors

  • Albuquerque RJ
  • Hayashi T
  • Cho WG
  • Kleinman ME
  • Dridi S
  • Takeda A
  • Baffi JZ
  • Yamada K
  • Kaneko H
  • Green MG
  • Chappell J
  • Wilting J
  • Weich HA
  • Yamagami S
  • Amano S
  • Mizuki N
  • Alexander JS
  • Peterson ML
  • Brekken RA
  • Hirashima M
  • Capoor S
  • Usui T
  • Ambati BK
  • Ambati J

Journal

Nature medicine

Publication Data

September 7, 2009

Associated Grants

  • Agency: NEI NIH HHS, Id: EY015422
  • Agency: NEI NIH HHS, Id: EY017182
  • Agency: NEI NIH HHS, Id: EY017950
  • Agency: NEI NIH HHS, Id: EY018350
  • Agency: NEI NIH HHS, Id: EY018836
  • Agency: NEI NIH HHS, Id: R01 EY015422
  • Agency: NEI NIH HHS, Id: R01 EY015422-04
  • Agency: NEI NIH HHS, Id: R01 EY018350
  • Agency: NEI NIH HHS, Id: R01 EY018350-04
  • Agency: NEI NIH HHS, Id: R01 EY018836
  • Agency: NEI NIH HHS, Id: R01 EY018836-04
  • Agency: NEI NIH HHS, Id: R01 EY020672
  • Agency: NEI NIH HHS, Id: R01 EY020672-01
  • Agency: NEI NIH HHS, Id: R21 EY019778
  • Agency: NEI NIH HHS, Id: R21 EY019778-01
  • Agency: NEI NIH HHS, Id: RC1 EY020442
  • Agency: NEI NIH HHS, Id: RC1 EY020442-01

Mesh Terms

  • Alternative Splicing
  • Animals
  • Animals, Newborn
  • Base Sequence
  • Cornea
  • DNA, Complementary
  • Humans
  • Lymphangiogenesis
  • Lymphatic Vessels
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Molecular Sequence Data
  • Vascular Endothelial Growth Factor C
  • Vascular Endothelial Growth Factor Receptor-2